Nexalin Technology (NXL) Return on Sales (2021 - 2026)

Nexalin Technology has reported Return on Sales for 6 years, with the latest figure at 1.4% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales fell 92.0% year-over-year to 1.4%; the trailing twelve-month figure through Mar 2026 stood at 0.3% (up 35.0% YoY), and the FY2025 full-year result was 0.27%, up 18.0% from the prior year.
• Return on Sales for Q1 2026 stood at 1.4%, down from 0.14% in the prior quarter.
• The five-year high for Return on Sales was 0.01% in Q3 2022, with the low at 1.4% in Q1 2026.
• Average Return on Sales over 5 years is 0.46%, with a median of 0.24% recorded in 2023.
• Year-over-year, Return on Sales slumped 95 bps in 2023 and soared 90 bps in 2025.
• Tracing NXL's Return on Sales over 5 years: stood at 0.19% in 2022, then tumbled by 99 bps to 0.38% in 2023, then sank by 174 bps to 1.04% in 2024, then surged by 87 bps to 0.14% in 2025, then plunged by 914 bps to 1.4% in 2026.
• The last three Return on Sales figures came in at 1.4% (Q1 2026), 0.14% (Q4 2025), and 1.25% (Q3 2025), per Business Quant data.

Peer Comparison